Molecular dynamics simulation study explaining inhibitor selectivity in different class of histone deacetylases

Sundarapandian Thangapandian1, Shalini John, Keun Woo Lee

  • 1Division of Applied Life Science (BK21 Program), Systems and Synthetic Agrobiotech Center (SSAC), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Research Institute of Natural Science (RINS), Gyeongsang National University (GNU), 501 Jinju-daero, Gazha-dong, Jinju, Republic of Korea.

Insights

Designing selective histone deacetylase (HDAC) inhibitors for cancer therapy is crucial. Molecular dynamics simulations reveal key interactions that dictate inhibitor selectivity for specific HDAC isoforms, guiding future drug design.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Histone deacetylases (HDACs) regulate gene expression and are cancer treatment targets.
  • Developing isoform-selective HDAC inhibitors is essential to minimize side effects.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the selectivity of HDAC inhibitors.
  • To provide insights for designing more effective and selective HDAC-based cancer therapies.

Main Methods:

  • Utilized molecular dynamics simulations to analyze interactions between selective inhibitors and HDAC isoforms.
  • Compared simulation results within and across different HDAC classes and isoforms.

Main Results:

  • Hydrogen bonds between protein and inhibitors directly correlate with selective activity.
  • Optimal distances between amino acids and the inhibitor's metal-binding site were identified.
  • Subtle amino acid differences in active sites explain observed experimental selectivity.

Conclusions:

  • Molecular dynamics simulations effectively elucidate HDAC inhibitor selectivity.
  • Findings offer valuable guidance for the rational design of highly selective HDAC inhibitors for cancer treatment.